Company Directory / Biotechnology Research
PrivateFor profitBiotechnology ResearchAurora, Ontario, Canada, Canada
Ovensa
Ovensa provides nanomedicine delivery platform with mucosal and brain-barrier crossing properties to generate advanced nanotherapeutics,
- Founded
- 2012 14 years ago
- Staff
- 1-10 2 on LinkedIn
- Followers
- 538 on LinkedIn
- Funding
- $1.9M as listed, USD
Ovensa is a Canadian preclinical stage company committed to advance its siRNA lead candidate silencing galectin-1 overexpression in the tumor microenvironment to improve therapeutic outcomes of an immuno-oncology anti-PD-1 checkpoint inhibitor as a combination therapy in head & neck cancer. The company is also advancing its collaboration programs with pharmaceutical companies to develop precision and combination medicines through its proprietary TRIOZAN™ Platform for specific indications.
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed. 2 people list it on LinkedIn.
Age
14 years old.
Reach
No web traffic ranking listed. 538 followers on LinkedIn.
What it does
BiotechnologyMedicalTherapeuticsPrecision & Combination MedicinesPeptide TherapeuticsImmuno-Oncology TherapeuticsCNS TherapeuticsDNA & RNA Based TherapeuticsTumor Microenvironment ModulationTargeted Conjugation & Multi-Combination Product DesignsNano ConjugatesNanoparticlesBrain TargetingExtracellular & Intracellular TargetingNon Lipidic & Non Viral
Funding, as listed
$1.9M raised in total
- Rounds2
- LatestSeed, Sept 2017
- Latest amountUSD 1,380,000
- Investors3
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Ovensa, field by field. Contact details are held but never shown.
The company
- Name
- Ovensa
- Type
- For profit
- Status
- Private
- Founded
- 2012
- Founders
- Philippe Tremblay, Stephane Gagne
- Industry
- Biotechnology Research
- Categories
- Biotechnology, Medical, Therapeutics
- Specialities
- Precision & Combination Medicines, Peptide Therapeutics, Immuno-Oncology Therapeutics, CNS Therapeutics, DNA & RNA Based Therapeutics, Tumor Microenvironment Modulation, Targeted Conjugation & Multi-Combination Product Designs, Nano Conjugates, Nanoparticles, Brain Targeting, Extracellular & Intracellular Targeting, Non Lipidic & Non Viral
Where
- City
- Aurora
- Region
- Ontario, Canada
- Country
- Canada
- Markets
- Great Lakes
Size and reach
- Staff band
- 1-10
- People on LinkedIn
- 2
- LinkedIn followers
- 538
Funding, as listed
- Total
- $1,910,000 USD
- Rounds
- 2
- Latest round
- Seed
- Latest round date
- Sept 2017
- Latest amount
- 1,380,000 USD
- Investors
- 3
- Listing status
- private
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Companies like it
Biotechnology Research in Canada.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.